NATO’s new role in tackling cyber threats
07 Dec 2016 – 15:00 | No Comment

We may not see cyber-attacks but they are happening every day, and with increasing severity. In the UK, 90% of large organisations have reported cyber breaches over the last two years and the average cost …

Read the full story »
International

EU Health

Transport

Circular Economy

Climate Change

Home » Archive by Author

Articles by Janani Krishnaswamy

Clinical and policy cooperation important in fight against cancer
08 Dec 2016 – 17:30 | No Comment
Clinical and policy  cooperation important in fight against cancer

While the work done by the European Parliament’s informal group MEP’s against Cancer and the European Partnership for Action Against Cancer will continue to develop on cancer prevention in Europe and improve policy between member …

NATO’s new role in tackling cyber threats
07 Dec 2016 – 15:00 | No Comment
NATO’s new role in tackling cyber threats

We may not see cyber-attacks but they are happening every day, and with increasing severity. In the UK, 90% of large organisations have reported cyber breaches over the last two years and the average cost …

Girding for battle in the cyber arena
07 Dec 2016 – 14:47 | No Comment
Girding for battle in the cyber arena

The digital age has opened up new possibilities to connect, allowing people to participate actively in social, cultural and political spheres. As a result, our economies have become more vulnerable to cyber threats. Afzal Khan …

How do we solve the hardest challenges in cancer?
06 Dec 2016 – 17:22 | No Comment
How do we solve the hardest  challenges in cancer?

Cancer Research UK has made lung cancer a priority and has increased funding towards the deadly disease as against other cancer types.   Dr. Karen Noble, Head of Research Training and Fellowships, Cancer Research UK, makes …

Children with cancer can’t wait any longer
06 Dec 2016 – 10:09 | No Comment
Children with cancer can’t wait any longer

The EU Paediatric Medicines Regulation has benefited a series of childhood diseases, yet only two innovative anti-cancer drugs have been authorised so far. Francoise Grossetete MEP analyses the impact of the legislation and points out …

Europe must do more to ensure children don’t miss out on life-saving treatments
05 Dec 2016 – 10:17 | No Comment
Europe must do more to ensure children don’t miss out on life-saving treatments

The EU Paediatric Medicines Regulation has resulted in far fewer treatments being made available for children than there should be. Glenis Willmott MEP reviews the regulation and points out what crucially needs changing  regarding current …

Relevance of policy in shaping personalised medicine and tackling lung cancer
05 Dec 2016 – 10:16 | No Comment
Relevance of policy in shaping personalised medicine and tackling lung cancer

Policymakers have a significant role to play in bringing about a Europe in which personalised medicine, in all its forms, can be integrated into healthcare systems. Denis Horgan, Executive Director, European Alliance for Personalised Medicine, …

‘Low-dose CT screening best for high-risk patients’
05 Dec 2016 – 10:14 | No Comment
‘Low-dose CT screening best for high-risk patients’

In the European Union, lung cancer is the 4th cancer in incidence with 313,000 new cases per year, but remains the number one killer, accounting to 268,000 deaths per year. Lung cancer represents 21% of all cancer deaths in …

Healthcare stakeholders join hands to fight lung cancer
05 Dec 2016 – 10:13 | No Comment
Healthcare stakeholders join hands to fight lung cancer

The 2016 Lung Cancer Europe Roundtableorganised by the International Centre for Parliamentary Studies took place in Brussels on Tuesday, 27th September. Members of the European Parliament, senior representatives from the World Health Organisation and European …

Illumina Launches TruSight Tumor 170
05 Dec 2016 – 10:00 | No Comment
Illumina Launches TruSight Tumor 170

Illumina’s newest addition in clinical cancer research portfolio aims to establish a standardised method for tumor profiling
Illumina, Inc. has launched TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the …